DE:SFY0 / Theriva Biologics, Inc. - Net Long/Short Value

Theriva Biologics, Inc.
DE ˙ DB
DE:SFY0 / Theriva Biologics, Inc. - Net Long/Short Value
Auf dieser Seite finden Sie die Netto-Long/Short-Bewertungen für jede institutionelle Beteiligung, die über die 13F- oder NPORT-Berichte gemeldet wurde. Um den Netto-Long/Short-Wert zu berechnen, addieren wir den Aktienwert zum Wert der Call-Option und ziehen den Wert der Put-Option ab. Fonds, die geliehene Short-Positionen melden, weisen den Aktienwert als negativ aus. Netto-Long-Positionen haben positive Zahlen in der Netto-Long/Short-Spalte, und Netto-Short-Positionen haben negative Werte in dieser Spalte.
Besitzer Eigenkapitalwert
($1000)
Call Wert
($1000)
Put Wert
($1000)
Net Long/Short
($1000)
Vanguard Fiduciary Trust Co
Advisor Group Holdings, Inc.
UBS Group AG
Vanguard Group Inc
IFP Advisors, Inc
Ikarian Capital, LLC
Geode Capital Management, Llc
Citigroup Inc
Schwarz Dygos Wheeler Investment Advisors Llc
XTX Topco Ltd
Danske Bank A/s
Newbridge Financial Services Group, Inc.
Royal Bank Of Canada
Two Sigma Securities, Llc
Barclays Plc
Two Sigma Investments, Lp
StoneX Group Inc.
Virtu Financial LLC
SBI Securities Co., Ltd.
Boothbay Fund Management, Llc
Vanguard Capital Management Llc
Morgan Stanley
BlackRock, Inc.
Jane Street Group, Llc
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
US:TOVX 0,26 $
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista